Latest Breaking News On - Translational therapeutics program - Page 1 : comparemela.com

Lung Specialist Finds His Sweet Spot at the Intersection of Medicine and Technology

David P. Carbone, MD, PhD, sought to transform lung cancer care and did it but didn’t anticipate the personal journey it would put him on.

Johns hopkins universityUnited statesUniversity of texas southwestern medical centerVanderbilt universityDana farber cancer instituteNew yorkJohns hopkins hospitalOhio state universityNational institutes of healthCancer instituteAl qahirahHaroldl mosesWilliam oslerBonniej addarioJasleen pannuHeidi onda

2 Ohio State medical scientists elected to the National Academy of Inventors

The National Academy of Inventors (NAI) has elected two professors in The Ohio State University College of Medicine to its 2023 class of Fellows.

United statesOhio state universityStefanie spielmanMichael tweedleKrystof bankiewiczPaulr sanbergUniversity of california at san franciscoBrain neurotherapy bio incJournal of nuclear medicineNational institutes of healthOhio state university college of medicineMedgenesis therapeutix incDepartment of radiologyOhio state university wexner medical centerInterventional neuro centers at brodno hospitalOhio state gene therapy institute

Conquering Lung Cancer

Conquering Lung Cancer
wcbe.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from wcbe.org Daily Mail and Mail on Sunday newspapers.

United statesOhio state universityBarbaraj bonnerDavidp carboneCierra johnsonJasleen pannuInterventional pulmonary translational researchJames thoracic centerOhio state university comprehensive cancer centerTranslational therapeutics programDivision of pulmonaryNational smoking cessation monthOhio state university wexner medical centerLung cancer researchStanford medicineLung cancer awareness

Dr Ramaswamy on the Real-World Data Implications of Palbociclib in HR-Positive Breast Cancer

Bhuvaneswari Ramaswamy, MD, discusses the importance of real-world data when considering the efficacy of the CDK 4/6 inhibitor palbociclib in hormone receptor–positive breast cancer.

Ohio state universityUnited statesBhuvaneswari ramaswamyOncology fellowship program in breast cancerOhio state college of medicineTranslational therapeutics programCancer centerMedical centerBreast medical oncologyMedical oncology fellowship programBreast cancerOhio state collegeHormone receptor positive her2 negative breast cancerHr positiveHer2 negativeJcdk4 6 inhibitor

Dr Hays on Unmet Needs in CRC
onclive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from onclive.com Daily Mail and Mail on Sunday newspapers.

Johnl haysTranslational therapeutics programOhio state universityOhio state university comprehensive cancer centerDepartment of internal medicineInternal medicine